RedHill Biopharma Ltd.

NasdaqCM:RDHL Stock Report

Market Cap: US$14.4m

RedHill Biopharma Management

Management criteria checks 4/4

RedHill Biopharma's CEO is Dror Ben-Asher, appointed in Aug 2009, has a tenure of 14.67 years. total yearly compensation is $594.61K, comprised of 79.6% salary and 20.4% bonuses, including company stock and options. directly owns 0.031% of the company’s shares, worth $4.42K. The average tenure of the management team and the board of directors is 3.9 years and 10.6 years respectively.

Key information

Dror Ben-Asher

Chief executive officer

US$594.6k

Total compensation

CEO salary percentage79.6%
CEO tenure14.7yrs
CEO ownership0.03%
Management average tenure3.9yrs
Board average tenure10.6yrs

Recent management updates

Recent updates

RedHill Biopharma Ltd. (NASDAQ:RDHL) Might Not Be As Mispriced As It Looks

Jul 28
RedHill Biopharma Ltd. (NASDAQ:RDHL) Might Not Be As Mispriced As It Looks

One RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Has Been Cutting Their Forecasts

Nov 24
One RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Has Been Cutting Their Forecasts

RedHill Biopharma receives Nasdaq notification regarding minimum bid price deficiency

Oct 18

RedHill wins EU’s orphan drug status to RHB-204 for rare lung disease

Aug 17

RedHill: Given Up For Dead

Apr 30

RedHill Biopharma: Looking At An Unexciting Dead-End

Dec 30

RedHill Biopharma Ltd. (NASDAQ:RDHL) Just Reported, And Analysts Assigned A US$15.79 Price Target

Dec 02
RedHill Biopharma Ltd. (NASDAQ:RDHL) Just Reported, And Analysts Assigned A US$15.79 Price Target

CEO Compensation Analysis

How has Dror Ben-Asher's remuneration changed compared to RedHill Biopharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$595kUS$473k

US$24m

Sep 30 2023n/an/a

US$34m

Jun 30 2023n/an/a

US$12m

Mar 31 2023n/an/a

-US$900k

Dec 31 2022US$865kUS$601k

-US$72m

Sep 30 2022n/an/a

-US$92m

Jun 30 2022n/an/a

-US$78m

Mar 31 2022n/an/a

-US$95m

Dec 31 2021US$1mUS$717k

-US$98m

Sep 30 2021n/an/a

-US$98m

Jun 30 2021n/an/a

-US$95m

Mar 31 2021n/an/a

-US$82m

Dec 31 2020US$817kUS$445k

-US$76m

Sep 30 2020n/an/a

-US$64m

Jun 30 2020n/an/a

-US$55m

Mar 31 2020n/an/a

-US$50m

Dec 31 2019US$708kUS$355k

-US$42m

Sep 30 2019n/an/a

-US$38m

Jun 30 2019n/an/a

-US$39m

Mar 31 2019n/an/a

-US$39m

Dec 31 2018US$576kUS$352k

-US$39m

Sep 30 2018n/an/a

-US$42m

Jun 30 2018n/an/a

-US$47m

Mar 31 2018n/an/a

-US$47m

Dec 31 2017US$634kUS$336k

-US$46m

Compensation vs Market: Dror's total compensation ($USD594.61K) is about average for companies of similar size in the US market ($USD677.87K).

Compensation vs Earnings: Dror's compensation has been consistent with company performance over the past year.

CEO

Dror Ben-Asher (57 yo)

14.7yrs

Tenure

US$594,612

Compensation

Mr. Dror Ben-Asher Co-Founded at RedHill Biopharma Ltd. and has been its Chief Executive Officer since August 3, 2009. Mr. Ben-Asher serves as an Associate of Mercator Group, LLC.He has been affiliated wi...

Leadership Team

NamePositionTenureCompensationOwnership
Dror Ben-Asher
Co-Founder14.7yrsUS$594.61k0.031%
$ 4.4k
Razi Ingber
Chief Financial Officerless than a yearUS$354.22k0.013%
$ 1.9k
Gilead Raday
Chief Operating Officer8yrsUS$379.96k0.019%
$ 2.8k
Adi Frish
Chief Corporate & Business Development Officer3.5yrsUS$353.70k0.021%
$ 3.0k
Rick Scruggs
Chief Commercial Officer5.2yrsUS$469.80k0.0090%
$ 1.3k
Alexandra Okmian
Senior Business Development & Investor Relations Manager4.3yrsno datano data
Reza Fathi
Senior Vice President of Research & Developmentless than a yearUS$419.98k0.014%
$ 2.0k
Guy Goldberg
Chief Business Officer11.8yrsUS$504.63k0.013%
$ 1.9k
June Almenoff
Chief Medical Officer3.3yrsno datano data
Patricia Anderson
Senior Vice President of Regulatory Affairsless than a yearno datano data

3.9yrs

Average Tenure

55yo

Average Age

Experienced Management: RDHL's management team is considered experienced (3.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dror Ben-Asher
Co-Founder14.7yrsUS$594.61k0.031%
$ 4.4k
Rick Scruggs
Chief Commercial Officer8.3yrsUS$469.80k0.0090%
$ 1.3k
Ofer Tsimchi
Independent Director12.9yrsno data0.0012%
$ 178.6
Ira Kalfus
Member of Advisory Board5.3yrsno datano data
Thomas Borody
Member of Advisory Boardno datano datano data
Shmuel Cabilly
Independent Director4.6yrsno data0.041%
$ 5.9k
Yechezkel Barenholz
Member of Advisory Boardno datano datano data
Ran Oren
Member of Advisory Boardno datano datano data
Eric Swenden
Independent Director13.9yrsno data0.0096%
$ 1.4k
Kenneth Reed
Independent Director14.3yrsno data0.061%
$ 8.8k
Jerry Rosenblatt
Member of Advisory Boardno datano datano data
Alla Felder
Independent Director4.8yrsno data0.0013%
$ 190.1

10.6yrs

Average Tenure

63.5yo

Average Age

Experienced Board: RDHL's board of directors are seasoned and experienced ( 10.6 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.